Formally called the Google Life Sciences, Verily, founded on 7th December 2015 is an Alphabet Inc. research organ that has a special interest in life science studies. The agency is focused in the Healthcare and Biotechnology field. Under new patent rights of the Alphabet Inc., Verily has unrolled a study with a quest of collecting highly comprehensive health information and use it as a blueprint in disease prevention.
What is project baseline?
Also known as the baseline study, this is a genomic and medical plan that is driven by verily life science towards ensuring a healthy human body. An initial study was led by, Stanford Medicine, Duke University School of Medicine, Verily, and Google.
According to the Wall Street Journal dated 24th July 2014, the initiative sought to enroll about 10,000 people, legible from 18 years of age and above to make a representation of their respective ages, medical histories, and backgrounds. Data from about 175 individuals will be anonymously collected in the first initiative before a larger number may be considered in the subsequent stages. The volunteers encompass a broad group including the healthy, those at high disease risk and others with chronic disorders.
A molecular biologist at the Google X, Andrew Conrad runs the project which has hired the services of over 100 experts from various science-oriented fields.
|Recommended for you|
|Latest projects in digital health sector|
|Blockchain technology for disease prevention|
|Role of phramaceutical companies in digital health India|
What is new in this promising healthcare project?
The uniqueness of the baseline project lies not on the aim to collect data from many individuals but in its quest to collect massive data covering a wider array of topics from many people for medical purposes.
The project seeks to enable doctors and other medical personnel to predict the manifestation of life-threatening diseases such as cardiac diseases and cancer much early compared to as it is currently. Baseline project aims to bring a new dawn of preventive health care rather than treatment.
How does the baseline project work?
- In summer 2014, Google began a recruitment program of 10,000 volunteers. They could collect body fluids including saliva, urine, blood, and tears for a pilot study. The sample body fluids collected could then be analyzed by a team led by Conrad and then design a broader study in collaboration with the Duke University and the Medical schools of Stanford.
- Also, the researchers will record the volunteers body fluid samples, genetic data, chest X-rays images and other information from the electrocardiogram.
- At the volunteer’s willingness, the researchers will also access additional data about them including insurance claims, e-health records, phone calls, text messages, social media activities and much more.
- The researchers issue the volunteers with sleep sensors and wearable devices which they wear during the day and sleep sensors are placed under the mattress during sleep. The devices and devices are meant to measure heart rate, sweat, and steps are seen only when they are wearing them.
- Throughout the project, the volunteers will be compensated, will be getting regular updates and insights into discoveries and will have access to the Baseline project community and events.
- After four years or longer elapse, the researchers will use the health information from volunteers’ annual visits to establish how individuals progress to ill from health.
Aim of the Verily baseline study
The primary goal of this Google initiative is to improve human health. The project seeks to contribute towards the scientific efforts more broadly meaningfully. Through the study, Google will be able to collect enough substantial data both from within and without the clinical realm for health mapping.
The initiative also wants to improve the accuracy of the of the clinical data collected by providing a broad set of measuring devices with repeat sampling through a period through the Baseline mobile app and the study watch.
The project serves as a meeting ground for a varied number of healthcare and scientific experts to put minds together in a united effort to map the human health. With the development and advancement of the available medical discovery tools, the researchers want to minimize the risk of growing chronic conditions by detecting and curbing diseases like cancer and heart diseases at initial stages.
Verily baseline partners
In early January 2017, Temasek, a Singapore-based investor announced its partnership with Verily in the Baseline project and injected $800 million as a company investment. Temasek is an investment company with an illustrious history of capital investments.
In late 2016, Nikon, a subsidiary of Optos signed a deal with Verily for the development of technologies for machine learning –based retinal imaging. Through this partnership, verily seeks to improve screening of conditions like diabetic macular edema and diabetic retinopathy, which are the leading causes of blindness in the globe.
A partnership of DexCom and verily seeks to develop a Continuous Glucose Monitoring (CGM) device in early 2018 followed by a disposable CGM planned for 2021.
Image credit: www.istockphoto.com